Malaria.com

Frequent Fever

by

QUESTION

I live in Mumbai,India. My mother’s age is 56. She is getting fever from last 1 month and also lost her appetite. We have tested for malaria but it is negative. Tried 4-5 doctors but no one is able to detect the exact cause. She feels better for 3-4 days after medication but then again gets a fever. She feels like vomiting while trying to eat something. Please help.

ANSWER

If the doctors have tested her for malaria and the test was negative, then she probably isn’t suffering from malaria. There are many other potential causes for her illness, from influenza to gastroenteritis. She should try to keep drinking plenty of fluids to stay rehydrated, and plain foods so as not to upset her stomach but keep her strength up. We are not able to give specific medical advice. If she is still feeling sick, you should consult another doctor and ask for a more comprehensive set of tests to determine the cause of illness (including blood tests and a faecal examination to look for parasites).

Anti-Infective Drugs Market to Reach $66 Billion by 2013, Says Report

by

The anti-infective drugs market will jump to $66 billion by 2013, according to a recently published report.

Anti-infective drugs include: anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Six infectious diseases — pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS — account for half of all premature deaths worldwide. With a worldwide death toll from infectious diseases exceeding 14 million, anti-infective drugs are vital.

To date, the most successful anti-infective drugs target the human immunodeficiency virus (HIV, the virus that causes AIDS), the herpes virus (HSV-1 and HSV-2), bacterial infections and hepatitis C (HCV). Truvada, Valtrex, Cravit, Floxin, Atripla, Pegasys, Kaletra and Reyataz are among the anti-infective drugs with the highest global sales.

The report, entitled  “Anti-Infective Drugs Markets,” was produced by TriMark Publications.

The “Anti-Infective Drugs Markets” report covers:

  • Pneumonia
  • Influenza
  • Avian Bird Flu
  • Sinusitis
  • Acute Suppurative Thyroiditis
  • Complicated Skin and Skin Structure Infections (cSSSIs)
  • Lymphadenitis
  • Pharyngotonsillitis
  • Vascular Infections
  • Pancreatitis
  • Urinary Tract Infections (UTIs)
  • Viral Encephalitis
  • Reye’s Syndrome
  • Blood-Borne Infections
  • Malaria
  • West Nile Virus

The “Anti-Infective Drugs Markets” report examines companies manufacturing anti-infective drugs equipment and supplies in the world. Companies covered include: Abraxis Bioscience, Acambis, Achillion, Adlyfe, Advanced Life Sciences Holdings, Affinium, Akonni Biosystems, Alnylam, APP, Aquapharm Biodiscovery, Arbor Vita, Arpida, Avexa, Basilea, Baxter, Biophage Pharma, CEL-SCI, Cerexa, Combimatrix, Cubist, Daiichi Sankyo, Hospira, Idenix, Incyte, Medivir, Meiji Holdings, MerLion, Mutabilis, Nanobio, Nanosphere, Nanoviricides, Novabay, Obetech, Optimer, Panacos, Paratek, Pharmasset, Pico, Polymedix, Powdermed, Presidio, Progenics, Protez, Rib-X, Ribomed, Targanta, Theravance, Trius, Vertex and X-GEN.

Detailed charts with sales forecasts and marketshare data are included.

More information: TriMark Publications.

Source: Business Wire